Exelixis, Inc. (EXEL)
Total Valuation
Exelixis has a market cap or net worth of $7.24 billion. The enterprise value is $6.43 billion.
Market Cap | 7.24B |
Enterprise Value | 6.43B |
Important Dates
The last earnings date was Thursday, February 16, 2023, after market close.
Earnings Date | Feb 16, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
Exelixis has 303.19 million shares outstanding. The number of shares has decreased by -0.95% in one year.
Shares Outstanding | 303.19M |
Shares Change (YoY) | -0.95% |
Shares Change (QoQ) | -1.95% |
Owned by Insiders (%) | 2.34% |
Owned by Institutions (%) | 87.45% |
Float | 255.76M |
Valuation Ratios
The trailing PE ratio is 36.51 and the forward PE ratio is 18.89. Exelixis's PEG ratio is 1.76.
PE Ratio | 36.51 |
Forward PE | 18.89 |
PS Ratio | 3.95 |
Forward PS | 3.74 |
PB Ratio | 3.20 |
P/FCF Ratio | 24.71 |
PEG Ratio | 1.76 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.60, with an EV/FCF ratio of 21.96.
EV / Earnings | 30.96 |
EV / Sales | 3.51 |
EV / EBITDA | 20.60 |
EV / EBIT | 24.98 |
EV / FCF | 21.96 |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.08.
Current Ratio | 3.34 |
Quick Ratio | 3.13 |
Debt / Equity | 0.08 |
Debt / EBITDA | 0.61 |
Debt / FCF | 0.65 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.60% and return on invested capital (ROIC) is 5.62%.
Return on Equity (ROE) | 8.60% |
Return on Assets (ROA) | 6.80% |
Return on Capital (ROIC) | 5.62% |
Revenue Per Employee | $1.40M |
Profits Per Employee | $158,599 |
Employee Count | 1,310 |
Asset Turnover | 0.60 |
Inventory Turnover | 2.87 |
Taxes
In the past 12 months, Exelixis has paid $49.76 million in taxes.
Income Tax | 49.76M |
Effective Tax Rate | 19.32% |
Stock Price Statistics
The stock price has increased by +26.43% in the last 52 weeks. The beta is 0.53, so Exelixis's price volatility has been lower than the market average.
Beta (1Y) | 0.53 |
52-Week Price Change | +26.43% |
50-Day Moving Average | 22.05 |
200-Day Moving Average | 21.47 |
Relative Strength Index (RSI) | 65.04 |
Average Volume (30 Days) | 2,337,514 |
Short Selling Information
The latest short interest is 8.25 million, so 2.72% of the outstanding shares have been sold short.
Short Interest | 8.25M |
Short Previous Month | 8.85M |
Short % of Shares Out | 2.72% |
Short % of Float | 3.23% |
Short Ratio (days to cover) | 3.27 |
Income Statement
In the last 12 months, Exelixis had revenue of $1.83 billion and earned $207.77 million in profits. Earnings per share was $0.65.
Revenue | 1.83B |
Gross Profit | 1.76B |
Operating Income | 170.89M |
Pretax Income | 257.52M |
Net Income | 207.77M |
EBITDA | 312.21M |
EBIT | 257.52M |
Earnings Per Share (EPS) | $0.65 |
Balance Sheet
The company has $995.30 million in cash and $189.94 million in debt, giving a net cash position of $805.36 million or $2.66 per share.
Cash & Cash Equivalents | 995.30M |
Total Debt | 189.94M |
Net Cash | 805.36M |
Net Cash Per Share | $2.66 |
Equity / Book Value | 2.26B |
Book Value Per Share | 7.47 |
Working Capital | 923.68M |
Cash Flow
In the last 12 months, operating cash flow was $333.32 million and capital expenditures -$40.47 million, giving a free cash flow of $292.86 million.
Operating Cash Flow | 333.32M |
Capital Expenditures | -40.47M |
Free Cash Flow | 292.86M |
FCF Per Share | $0.92 |
Margins
Gross margin is 96.04%, with operating and profit margins of 9.34% and 11.35%.
Gross Margin | 96.04% |
Operating Margin | 9.34% |
Pretax Margin | 14.07% |
Profit Margin | 11.35% |
EBITDA Margin | 17.06% |
EBIT Margin | 14.07% |
FCF Margin | 16.00% |
Dividends & Yields
Exelixis does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.95% |
Shareholder Yield | 0.95% |
Earnings Yield | 2.87% |
FCF Yield | 4.05% |
Analyst Forecast
The average price target for Exelixis is $26.79, which is 12.90% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $26.79 |
Price Target Difference | 12.90% |
Analyst Consensus | Strong Buy |
Analyst Count | 14 |
Revenue Growth Forecast (5Y) | 7.95% |
EPS Growth Forecast (5Y) | 30.53% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Exelixis has an Altman Z-Score of 7.61 and a Piotroski F-Score of 7.
Altman Z-Score | 7.61 |
Piotroski F-Score | 7 |